CA1259611A - 5-substituted 2-pyrimidinone nucleosides and methods of use - Google Patents

5-substituted 2-pyrimidinone nucleosides and methods of use

Info

Publication number
CA1259611A
CA1259611A CA000461607A CA461607A CA1259611A CA 1259611 A CA1259611 A CA 1259611A CA 000461607 A CA000461607 A CA 000461607A CA 461607 A CA461607 A CA 461607A CA 1259611 A CA1259611 A CA 1259611A
Authority
CA
Canada
Prior art keywords
pyrimidinone
ribofuranosyl
deoxy
beta
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000461607A
Other languages
English (en)
French (fr)
Inventor
Thomas J. Bardos
Yung-Chi Cheng
Alan C. Schroeder
Simon M.N. Efange
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of State University of New York
Original Assignee
Research Foundation of State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of State University of New York filed Critical Research Foundation of State University of New York
Application granted granted Critical
Publication of CA1259611A publication Critical patent/CA1259611A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000461607A 1984-08-20 1984-08-23 5-substituted 2-pyrimidinone nucleosides and methods of use Expired CA1259611A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/641,770 US4782142A (en) 1982-01-05 1984-08-20 Novel 5-substituted 2-pyrimidinone nucleosides and methods of use
US641,770 1984-08-20

Publications (1)

Publication Number Publication Date
CA1259611A true CA1259611A (en) 1989-09-19

Family

ID=24573773

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000461607A Expired CA1259611A (en) 1984-08-20 1984-08-23 5-substituted 2-pyrimidinone nucleosides and methods of use

Country Status (5)

Country Link
US (1) US4782142A (de)
EP (1) EP0175004B1 (de)
JP (1) JPS6153296A (de)
CA (1) CA1259611A (de)
DE (1) DE3480928D1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517402D0 (en) * 1985-07-10 1985-08-14 Wellcome Found Treatment of viral infections
JPH0217199A (ja) * 1988-07-05 1990-01-22 Japan Tobacco Inc ２’−デオキシ−β−アデノシンの製造方法
JPH0217198A (ja) * 1988-07-05 1990-01-22 Japan Tobacco Inc ２’−デオキシ−β−シチジン誘導体およびその塩の製造法
EP0428623A4 (en) * 1988-08-10 1993-12-08 Stephen Leslie Sacks Production of radioiodinated 1--g(b)-d-arabinofuranosyl)-5(e)-(2-iodovinyl)uracil, and uses thereof, and related analogues incorporating alternative halogen radionuclides, the general radiohalogenation precursors, 1-(2,3,5-tri-o-acetyl--g(b)-d-arabinofuranosyl)-5(z and e)-(2-trimethylsilylvinyl)urac
JPH02160799A (ja) * 1988-12-13 1990-06-20 Yuki Gosei Kogyo Co Ltd ２′−デオキシ−β−アデノシンの製造法
US5214138A (en) * 1989-12-20 1993-05-25 Case Western Reserve University Imidazopyridinium compound and processes for isolating, identifying, and chemically synthesizing same
CA2103050A1 (en) * 1991-05-15 1992-11-16 Yung-Chi Cheng Determination of prodrugs metabolizable by the liver and therapeutic use thereof
US5306722A (en) * 1992-09-02 1994-04-26 Bristol-Myers Squibb Company Thymidine derivatives and therapeutic method of use
CA2119315A1 (en) * 1993-03-18 1994-09-19 Tsujiaki Hata Nucleoside derivatives and anti-herpes composition
CN107540718B (zh) * 2017-10-26 2020-01-31 天津立博美华基因科技有限责任公司 1-（2-脱氧-β-D-呋喃核糖基）-5-碘-2-嘧啶酮的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
DD134429A3 (de) * 1977-09-29 1979-02-28 Dieter Cech Verfahren zur herstellung von 1-(beta-d-ribofuranosyl)-5-fluorpyrimidin-2-on
GB2060604B (en) * 1979-10-03 1983-11-23 Univ Birmingham And Stichting E15-(2-halogenovinyl)-2'-deoxycytidines
JPS5687599A (en) * 1979-12-19 1981-07-16 Yamasa Shoyu Co Ltd E 55 22halogenovinyl arabinofuranosyluracil and its preparation

Also Published As

Publication number Publication date
EP0175004A2 (de) 1986-03-26
DE3480928D1 (de) 1990-02-08
EP0175004B1 (de) 1990-01-03
JPS6153296A (ja) 1986-03-17
EP0175004A3 (en) 1986-07-30
US4782142A (en) 1988-11-01

Similar Documents

Publication Publication Date Title
Perez-Perez et al. TSAO analogs. Stereospecific synthesis and anti-HIV-1 activity of 1-[2', 5'-bis-O-(tert-butyldimethylsilyl)-. beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'', 2''-oxathiole-2'', 2''-dioxide) pyrimidine and pyrimidine-modified nucleosides
DE68926137T2 (de) Pyrimidin-Nukleoside
US5756711A (en) Phospholipid derivatives of nucleosides and their use as anti-viral medicaments
AU737902B2 (en) Anti-viral pyrimidine nucleoside analogues
Lin et al. Synthesis and antineoplastic activity of 3'-azido and 3'-amino analogs of pyrimidine deoxyribonucleoside
US5559101A (en) L-ribofuranosyl nucleosides
US4663446A (en) N2 (phenyl substituted) deoxy guanosine containing compounds
US4177348A (en) Carbocyclic analogs of cytosine nucleosides
JPH0662663B2 (ja) デスアザプリン―ヌクレオシド―誘導体
CA2220642A1 (en) C-4' modified adenosine kinase inhibitors
US5616567A (en) 2'-Cyano pyrimidine nucleoside compounds
CA1259611A (en) 5-substituted 2-pyrimidinone nucleosides and methods of use
KR20000049224A (ko) 모노시클릭 ｌ-누클레오시드, 이의 유사체 및 이들의 용도
EP0484333A1 (de) Nucleosid-derivate und deren verwendung als arzneimittel.
EP0793669A1 (de) Dimere l-nukleoside und ihre therapeutische verwendung
US5219840A (en) Antihypertensive 9-(2,N6 -disubstituted adenyl) ribofuranuronic acid derivatives
US6114520A (en) 5'-deoxy-cytidine derivatives
US4396623A (en) Carbocyclic analogs of uracil nucleosides as antiviral agents
US4468384A (en) Method for the inhibition of the replication of DNA viruses with 5-substituted 2-pyrimidinone nucleosides
EP0129984B1 (de) 2'-Desoxy-5-substituierte Uridin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Antitumor- Zusammensetzungen
WO1996032403A2 (de) Neue cytosin- und cytidinderivate
US4232154A (en) Carbocyclic analogs of cytosine nucleosides exhibiting antiviral and antineoplasticactivity
US4895937A (en) 5-ioso-2-pyrimidinone nucleoside
Siddiqui et al. Chemistry and anti-HIV properties of 2'-fluoro-2', 3'-dideoxyarabinofuranosylpyrimidines
Mitchell et al. Synthesis and antiviral properties of 5-(2-substituted vinyl)-6-aza-2'-deoxyuridines

Legal Events

Date Code Title Description
MKEX Expiry